VivaDiag Antigen Rapid test

VivaDiag ™ SARS-Cov-2 Ag Rapid Test

Both tests are designed to detect the presence of SARS-CoV-2 viral antigens in nasal, nasopharyngeal, or oropharyngeal swab samples from patients with suspected COVID-19. They are intended to be used by healthcare professionals for qualitative screening. Using lateral flow-based technology, the VivaDiag ™ SARS-CoV-2 Ag Rapid Test is easy to use and can generate results in 15 minutes, without the need for any other reading instruments. The rapid antigen test is extremely useful for places like the airport, the train station, and the convention center.

The VivaDiag ™ SARS-Cov-2 Ag FIA Test with the POCT VivaDiag ™ Analyzer employs our advanced fluorescent immunoassay platform technology. Its capacity for high analytical precision and high throughput (up to 120 tests per hour) makes it an indispensable tool for the screening, diagnosis, and containment of COVID-19. Neither of the above two products is available for sale in the US yet, although VivaChek is seeking emergency use authorization (US) from the USFDA.

Unfortunately, anyone can see the end of the global pandemic and with the upcoming regular flu season, the mission of fighting COVID-19 seems even more difficult. VivaChek is proud to invest all of our knowledge and resources to develop the VivaDiag ™ SARS-CoV-2 FIA / Flu A / Flu B Ag Combination Test, which will be released in the coming weeks. It can be used for the simultaneous detection and differentiation of SARS-CoV-2, influenza A and influenza B antigens in samples from individuals suspected of respiratory viral infections. The test will serve as a powerful weapon for healthcare professionals to contain the COVID-19 pandemic.

Leave a Reply

Your email address will not be published. Required fields are marked *

ABM HSA Mirna inhibitor
anti his hrp Blog culture vessel pakt antibody Product recombinant protein a rtk array wdhd1 western blot image

hsa miR miRNA Inhibitor ABM

Background Non-coding RNAs and significantly microRNAs have been discovered to behave as grasp regulators of most cancers initiation and improvement. The intention of our analysis was to seek out and characterize the carry out of however functionally uncharacterized microRNAs in human breast carcinogenesis. miRNA inhibitors block miRNA regulation of purpose gene expression by safe suppression […]

Read More
HRP Conjugated Arachis
anti his hrp Blog culture vessel pakt antibody Product recombinant protein a rtk array us biological antibodies western blot image

HRP Conjugated Arachis

Preparation Discover Prepared from peroxidase (P8375) using a modification of a broadcast method, which favors low molecular weight conjugates. Repurified after conjugation by affinity chromatography. Biochem/Physiol Actions PNA would not agglutinate common human erythrocytes, nevertheless strongly agglutinates neuraminidase dealt with erythrocytes. PNA has potent anti-T train very similar to the anti-T antibody in human sera. […]

Read More
anti his hrp Blog culture vessel cybrd1 pakt antibody Product recombinant protein a rtk array us biological antibodies western blot image

Amyloid Beta Protein

DESCRIPTION Amino Acid Sequence Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val Fundamental description Amyloid β Protein Fragment 1-40 (Aβ40) is derived from the amyloid-β protein (Aβ), which is mapped to human chromosome 21q21.3. Aβ40 is predominantly present inside the vascular amyloid deposits. Aβ40 accommodates of C-terminal membrane insertion space. It reveals structural transition from random coil to a α-helical building in […]

Read More